Vascular Endothelial Growth Factor Receptor-Targeted Therapy in Succinate Dehydrogenase C Kidney Cancer

J Clin Oncol. 2016 Mar 20;34(9):e76-9. doi: 10.1200/JCO.2013.51.0214. Epub 2014 Jul 14.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Intramural

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / enzymology
  • Carcinoma, Renal Cell / genetics
  • Carcinoma, Renal Cell / therapy
  • Combined Modality Therapy
  • Female
  • Germ-Line Mutation
  • Humans
  • Indoles / therapeutic use*
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / enzymology
  • Kidney Neoplasms / genetics
  • Kidney Neoplasms / therapy
  • Membrane Proteins / genetics*
  • Membrane Proteins / metabolism
  • Middle Aged
  • Molecular Targeted Therapy
  • Pedigree
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrroles / therapeutic use*
  • Sunitinib
  • Vascular Endothelial Growth Factor Receptor-1 / antagonists & inhibitors*
  • Vascular Endothelial Growth Factor Receptor-1 / metabolism

Substances

  • Antineoplastic Agents
  • Indoles
  • Membrane Proteins
  • Protein Kinase Inhibitors
  • Pyrroles
  • SDHC protein, human
  • FLT1 protein, human
  • Vascular Endothelial Growth Factor Receptor-1
  • Sunitinib